G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
about
Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesGraft failure in the modern era of allogeneic hematopoietic SCT.High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma.A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation.Optimal use of G-CSF administration after hematopoietic SCT.Recent advances on cellular therapies and immune modulators for graft-versus-host disease.Immunotherapy for infectious diseases in haematological immunocompromise.HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia.Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.Administration of G-CSF from day +6 post-allogeneic hematopoietic stem cell transplantation in children and adolescents accelerates neutrophil engraftment but does not appear to have an impact on cost savings.Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation
P2860
Q27014857-57AD0655-1287-4D35-A0F0-1990B959BC3FQ33404733-3AC2F77A-215C-455B-B948-7F8D0E758CCFQ33950015-46B2E9C4-04F5-4935-856E-F05A46623A0FQ35848659-9B2860AF-D1AE-4F41-9D05-476ED8D40510Q36936723-36C3A4F6-E1B8-4F91-8B71-F7A4EA58EFECQ37262618-9E1EC281-9D87-402F-99FE-0F50D5C5EB7CQ37442645-83565D0A-6899-47DE-B4C6-AF964DAD6007Q38246755-98064BBD-536A-48CB-A563-3ACE87B92D30Q39215653-4518AAC4-63C2-4003-8D08-561E03BED224Q41809107-21A24CBF-3964-4E85-A3F5-A80AD6A0AD7AQ43430861-CF83078F-26DB-4CB4-A8FA-80B41756A2C2Q46822195-A3765642-7AAB-4C79-BCB6-CAE0244E7D5AQ47742900-D7A9573D-22DC-49B0-9D55-E10862D9262EQ50777164-6DCF10A2-4879-413D-9517-45D0453E4ABAQ51729292-7F6173C5-8F10-4FCD-85D4-FA9DC4D73C4DQ53185657-6990C267-ABF9-4F5E-ABCD-65B4B6728A78Q53665940-9A6C6646-C648-46B4-8041-C7E39FABB2EEQ57217484-7117ED89-4B1A-4152-8B21-17F23928F5DA
P2860
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@en
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@nl
type
label
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@en
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@nl
prefLabel
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@en
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@nl
P2093
P2860
P356
P1476
G-CSF given after haematopoiet ...... incidence of acute GVHD II-IV.
@en
P2093
Barkholt L
Remberger M
Svennberg P
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704108
P407
P577
2003-07-01T00:00:00Z